A practical reference on Visceral adipose tissue: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-06-20 and is reviewed periodically as new material appears.
A documented effect of tesamorelin is a reduction in visceral adipose tissue in some study populations. Researchers have reported decreases in trunk fat measured by computed tomography alongside changes in lipid markers. The mechanism is thought to involve growth hormone-mediated lipolysis, though the precise contribution of direct versus indirect pathways is not fully resolved. Studies have generally examined defined groups over finite periods, so long-term outcomes are less well characterized. Findings have not been uniform across all trials.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). Its sequence corresponds to the 44-amino-acid form of human GHRH with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification slows enzymatic cleavage and extends the peptide's activity relative to the native hormone. The compound is produced by solid-phase peptide synthesis and supplied as a lyophilized powder. Researchers classify it as a GHRH receptor agonist. Its structure places it in the same family as other growth hormone secretagogues that act on the pituitary.
Insulin-like growth factor 1 is produced largely in the liver in response to growth hormone signaling. Its concentration shifts over days rather than minutes, which makes it practical for tracking changes across a study period. Interpretation still depends on age, nutritional status, and concurrent illness, all of which independently affect the marker. Reference ranges are therefore stratified, and comparisons are usually made within an individual over time rather than against a single population threshold.
Assays for these markers differ in calibration and antibody specificity, so results from different platforms are not always interchangeable. Reported values can shift when a laboratory changes method, even without any biological change. Studies that span long periods or multiple sites often need cross-validation of assays. This methodological variability is a recognized limitation when comparing findings across published reports, and it remains a topic of ongoing standardization work.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | GHRH receptor agonist |
| Residue count | 44 amino acids | N-terminal trans-3-hexenoyl group |
| Approximate mass | About 5.1 kDa | Derived from the peptide sequence |
| Primary target | Pituitary GHRH receptor | Somatotroph cells of the anterior pituitary |
| Downstream marker | IGF-1 | Measured indirectly in circulation |
Several compounds share the GHRH framework, including sermorelin, the shorter 1-29 fragment, and other analogs built on the full 1-44 chain. Naming follows a common convention: a stem that identifies the peptide plus a suffix marking analog status. Reports may describe tesamorelin by its sequence fragment, as a GHRH(1-44) analog, or by its amino-terminal modification. Indexing the compound therefore requires searching all of these forms, since some older literature predates the current international nonproprietary name.
Tesamorelin is a synthetic peptide built from 44 amino acids and classified with the growth hormone–releasing hormone family. Its sequence corresponds to the human GHRH(1-44) backbone, carrying one structural change at the amino terminus. That change is a trans-3-hexenoyl group placed where the natural peptide would have an unmodified end. The modification is the feature that separates the compound from the endogenous hormone in name, in stability, and in how it is handled in the laboratory.
Practical handling centers on limiting moisture, oxygen, and temperature excursions. Lyophilized material is generally held at or below minus twenty degrees Celsius, protected from light and kept sealed until use. Once reconstituted, solutions are typically kept cold and used within a short window because hydrolysis and microbial growth both accelerate in liquid form. Repeated freeze-thaw cycles are avoided, since they promote aggregation. Vial contents should be inspected for particulates and clarity before analysis, and working aliquots are prepared to reduce the number of times the stock is opened.
Quantitation of the peptide relies mainly on reversed-phase high-performance liquid chromatography with ultraviolet detection, typically at 214 nanometers, where the peptide bond absorbs. Identity is confirmed by mass spectrometry, most often electrospray ionization coupled to liquid chromatography, and by peptide mapping after enzymatic digestion. Because related impurities differ only slightly in sequence or modification, method development emphasizes resolution rather than speed. Purity is usually reported as a percentage of the main peak area, with individual impurities listed separately when they exceed a defined reporting threshold.
Clinical study of tesamorelin has centered on adults with HIV-associated lipodystrophy, a condition in which abdominal fat accumulates while peripheral fat is lost. In controlled trials, treated participants showed reductions in visceral adipose tissue measured by imaging, alongside modest shifts in some lipid values. Effects on subcutaneous fat were smaller and less consistent across studies. Whether these changes translate into fewer cardiovascular events remains an open question, because the trials were not designed or powered to answer it.
Tesamorelin is a synthetic peptide that acts as an analog of growth hormone-releasing hormone, a natural hypothalamic signal. Its sequence corresponds to the forty-four amino acid form of the human hormone, with a small acyl group attached near the amino terminus. That modification slows enzymatic breakdown and extends the time the peptide remains active in circulation. The compound was developed as a pharmacological way to raise endogenous growth hormone output rather than supplying the hormone directly.
After injection, the peptide binds receptors on somatotroph cells in the anterior pituitary. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone into the bloodstream. Because the compound works through the body's own regulatory system, growth hormone pulses retain much of their normal feedback control. Repeated administration also raises insulin-like growth factor 1, a hormone produced mainly in the liver. Investigators treat that rise as a marker that the pituitary axis has been engaged.
Once reconstituted, the peptide is handled as a solution and is less stable than the lyophilized powder. Aqueous solutions are commonly kept cold and used within a defined period. Buffer composition and pH influence degradation rates, with extremes of acidity or alkalinity accelerating hydrolysis. Preservatives may be added in multi-dose formats to limit microbial growth. Freezing and thawing of solutions is generally avoided because it can cause precipitation or loss of activity.
Identity and purity are assessed by reversed-phase high-performance liquid chromatography, which separates the peptide from related impurities. Mass spectrometry, often coupled to liquid chromatography, confirms molecular mass and detects chemical modifications. Peptide mapping and amino acid analysis can verify sequence integrity. Water content is measured by Karl Fischer titration, and residual solvents may be checked by gas chromatography. These methods together support batch-to-batch consistency and routine quality control.
Lyophilized tesamorelin is generally stored refrigerated at temperatures between 2 and 8 degrees Celsius. The solid form is comparatively stable when kept dry and protected from light. Moisture uptake can promote aggregation and degradation, so sealed containers with desiccant are common. Researchers typically avoid repeated temperature cycling, which may stress the peptide. Documentation accompanying reference materials usually specifies a shelf life under these conditions.
Some anesthetics and chemotherapy drugs are injected intrathecally into the subarachnoid space, where they spread around CSF, meaning substances that cannot cross the blood–brain barrier can still be active throughout the central nervous system. Baricity refers to the density of a substance compared to the density of human cerebrospinal fluid and is used in regional anesthesia to determine the manner in which a particular drug will spread in the intrathecal space. Liquorpheresis is the process of filtering the CSF in order to clear it from endogen or exogen pathogens. It can be achieved by means of fully implantable or extracorporeal devices, though the technique remains experimental today.
It is expected that improvement of experimental sensitivity will allow discovery of very mild radioactivity of some isotopes now considered stable. For example, in 2003 it was reported that bismuth-209 (the only primordial isotope of bismuth) is very mildly radioactive, with half-life (1.9 ± 0.2) × 1019 yr, confirming earlier theoretical predictions from nuclear physics that bismuth-209 would very slowly alpha decay. Isotopes that are theoretically believed to be unstable but have not been observed to decay are termed observationally stable. Currently there are 105 "stable" isotopes which are theoretically unstable, 40 of which have been observed in detail with no sign of decay, the lightest in any case being 36Ar. Many "stable" nuclides are metastable but have not been observed to decay, and are expected to undergo very rare kinds of radioactive decay, including double beta decay. 146 nuclides from 62 elements with atomic numbers from 1 (hydrogen) to 66 (dysprosium) except 43 (technetium), 61 (promethium), 62 (samarium), and 63 (europium) are theoretically stable to any kind of nuclear decay — except for the theoretical possibility of proton decay, which has never been observed despite extensive searches for it; and spontaneous fission (SF), which is theoretically possible for the nuclides with atomic mass numbers ≥ 93, that is all those with atomic numbers ≥ 41. Besides SF, other theoretical decay routes for heavier elements include:
Neutral Protamine Hagedorn (NPH) insulin, or isophane insulin, is an intermediate-acting insulin developed in 1946 to extend insulin activity through the addition of protamine, which slows absorption. It has an onset of about 90 minutes and lasts up to 24 hours, making it suitable for once- or twice-daily administration. NPH insulin is available as a recombinant human insulin and is sometimes premixed with short-acting insulin for combined basal and mealtime glucose control. During the 1980s, many individuals experienced difficulties when transitioning to intermediate-acting insulins, particularly NPH formulations of porcine and bovine insulins. These issues stemmed from variability in absorption and inconsistent glucose control. In response, basal insulin analogues were developed to provide a more stable and predictable absorption profile, leading to improved clinical efficacy and glycemic management.
Only when the South Ossetians opened up with artillery on Georgian villages, did the offensive to take Tskhinvali begin." The cable also says, "All evidence available to the country team supports Saakashvili's statement that this fight was not Georgia's original intention. Key Georgian officials, who would have had responsibility for an attack on South Ossetia have been on leave, and the Georgians only began mobilizing August 7 once the attack was well underway." The cable reported, "Fighting had continued throughout the night of August 7, resuming four hours after President Saakashvili unilaterally declared a cease-fire at 1900." The cable noted, "Although most in the Georgian government believed that the fighting had started as a ploy of de facto leader Kokoity, Saakashvili was now concerned that this might have been a Russian pretext and a further attack could be expected." The cable also reported that "The Georgians believe the South Ossetians are targeting the Russians to provoke a bigger Georgian-Russian conflict" and named the person responsible for the escalation of the conflict, "One plausible explanation for all this is that de facto leader Kokoity decided to roll the dice and stimulate a conflict with the Georgians in hopes of bringing in the Russians and thereby saving himself or enhancing his position." The cable reported that Russia had launched 4 ballistic missiles against Tskhinvali. The cable reported that the Georgians were fighting with unidentified Russian combatants north of Tskhinvali.
Sources: en.wikipedia.org
==== Icy surface bodies of water ==== Cold-start theories presuppose large ice-covered regions. Stellar evolution models predict that the Sun's luminosity was ≈25% weaker than it is today. Fuelner states that although this significant decrease in solar energy would have formed an icy planet, there is strong evidence for the presence of liquid water, possibly driven by a greenhouse effect. This would mean an early Earth with both liquid oceans and icy poles. Ice melts that form from ice sheets or glacier melts create freshwater pools, another niche capable of wet-dry cycles. While surface pools would be exposed to intense UV radiation, bodies of water within and under ice would be shielded, while remaining connected to exposed areas through ice cracks. Impact melting would allow freshwater and meteoritic input, creating prebiotic components. Near-seawater levels of sodium chloride destabilize fatty acid membrane self-assembly, making freshwater settings appealing for early membranous life. Icy environments would trade the faster reaction rates that occur in warm environments for increased stability and accumulation of larger polymers. Experiments simulating Europa-like conditions of ≈20 °C have synthesised amino acids and adenine, showing that Miller-Urey type syntheses can occur at low temperatures. In an RNA world, the ribozyme would have had even more functions than in a later DNA-RNA-protein-world. For RNA to function, it must be able to fold, a process hindered by temperatures above 30 °C.
Prolidase deficiency (PD) is an extremely uncommon autosomal recessive disorder associated with collagen metabolism that affects connective tissues and thus a diverse array of organ systems more broadly, though it is extremely inconsistent in its expression. Collagen is a structural protein found i.a. in bone, skin and connective tissues that is broken down into iminodipeptides at the end of its lifecycle. Of these dipeptides, those containing C-terminal proline or hydroxyproline would normally be broken down further by the enzyme Prolidase, recovering and thus recycling the constituent amino acids. Due to a genetic defect, prolidase activity in individuals with PD is either knocked out or severely reduced. Those affected therefore eliminate excessive amounts of iminodipeptides in their urine, wasting this precious resource, with debilitating effects.
=== Impulsive aggression === Fluoxetine is considered a first-line medication for the treatment of impulsive aggression of low intensity. Fluoxetine reduced low-intensity aggressive behavior in patients in intermittent explosive disorder and borderline personality disorder. Fluoxetine also reduced acts of domestic violence in alcoholics with a history of such behavior.
=== Legal status === Tividenofusp alfa was approved for medical use in the United States in March 2026. The US Food and Drug Administration (FDA) granted the application for tividenofusp alfa breakthrough therapy, fast track, priority review, and orphan drug designations. The FDA granted accelerated approval for Avlayah to Denali Therapeutics.
Anti-Peruvian (Spanish: Antiperuanismo), or Peruvophobia, refers to negative feelings, fear, hatred and discrimination toward and/or against Peruvians based on a combination of historical, cultural, and ethnic prejudices. It arose since the 19th century in some societies as a consequence of their territorial expansion. It germinated as a tendency in the nationalisms of neighboring countries, mainly Ecuador, Chile and to a lesser extent due to the disputed origin of different cultural manifestations, such as recipes and gastronomic preparations (such as pisco or picarones) or folkloric dances (such as the diablada or the morenada) whose origin is disputed or shared with Chile and Bolivia. In addition, due to different political and ideological differences with the Bolivarian leaders and their Chavista sympathizers in Venezuela. It can manifest itself in many ways, such as individual hatred or discrimination, tabloid media, attacks by groups organized for that purpose, even on social networks.
Sources: en.wikipedia.org
== External links == Cytogenetic Directory Cytogenetics Resources Archived 2017-05-26 at the Wayback Machine Human Cytogenetics - Chromosomes and Karyotypes Association for Genetic Technologists Association of Clinical Cytogeneticists Archived 2000-01-17 at the Wayback Machine Gladwin Medical Blog Archived 2006-11-08 at the Wayback Machine Cytogenetics - Technologies, markets and companies Cytogenetics-methods-and-trouble-shooting Department of Cytogenetics of Wikiversity
Levacetylmethadol (INN), levomethadyl acetate (USAN), OrLAAM (trade name) or levo-α-acetylmethadol (LAAM) is a synthetic opioid similar in structure to methadone. It has a long duration of action due to its active metabolites.
=== Pharmacokinetics === Unlike serotonin, αMS is not metabolized by monoamine oxidase on account of the α-methyl substituent blocking the enzyme's access to the amine. Similarly to serotonin however, αMS poorly crosses the blood–brain barrier due to its free hydroxyl group and poor lipophilicity, and thus may have weak or no central effects when administered peripherally.
Some nuclei can undergo double beta decay (2β) where the charge of the nucleus changes by two units. Double beta decay is difficult to study, as it has an extremely long half-life. In nuclei for which both β decay and 2β are possible, the rarer 2β process is effectively impossible to observe. However, in nuclei where β decay is forbidden but 2β is allowed, the process can be seen and a half-life measured. Thus, 2β is usually studied only for beta stable nuclei. Like single beta decay, double beta decay does not change A; thus, at least one of the nuclides with some given A has to be stable with regard to both single and double beta decay. "Ordinary" 2β results in the emission of two electrons and two antineutrinos. If neutrinos are Majorana particles (i.e., they are their own antiparticles), then a decay known as neutrinoless double beta decay will occur. Most neutrino physicists believe that neutrinoless 2β has never been observed.
Adnexal mass entry in the public domain NCI Dictionary of Cancer Terms Emedicine overview This article incorporates public domain material from Dictionary of Cancer Terms. U.S. National Cancer Institute.
Sources: en.wikipedia.org
It mirrors the 44-residue form of human growth hormone-releasing hormone. A hexenoyl group on the N-terminal tyrosine distinguishes it from the unmodified hormone. The change is intended to improve resistance to enzymatic breakdown.
The N-terminal modification reduces cleavage by circulating peptidases, so the peptide persists longer than native GHRH. That persistence is the main rationale for the synthetic design. Comparative half-life values in humans are reported in regulatory review documents rather than in general reference literature.
Reductions in visceral adipose tissue have been measured in controlled studies of defined populations. Whether the effect generalizes to other groups and persists after treatment stops is less clear. Longer-term outcome data remain limited.
It varies slowly and reflects cumulative axis activity rather than momentary secretion. Growth hormone is released in pulses affected by sleep, stress, and meals, making single readings hard to interpret. The slower marker gives a more stable picture across a study period.